ATE422356T1 - Pharmazeutische zubereitungen - Google Patents
Pharmazeutische zubereitungenInfo
- Publication number
- ATE422356T1 ATE422356T1 AT04732650T AT04732650T ATE422356T1 AT E422356 T1 ATE422356 T1 AT E422356T1 AT 04732650 T AT04732650 T AT 04732650T AT 04732650 T AT04732650 T AT 04732650T AT E422356 T1 ATE422356 T1 AT E422356T1
- Authority
- AT
- Austria
- Prior art keywords
- chitosan
- drug compound
- derivative
- salt
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0310919.6A GB0310919D0 (en) | 2003-05-13 | 2003-05-13 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE422356T1 true ATE422356T1 (de) | 2009-02-15 |
Family
ID=9957934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04732650T ATE422356T1 (de) | 2003-05-13 | 2004-05-13 | Pharmazeutische zubereitungen |
Country Status (7)
Country | Link |
---|---|
US (2) | US20060115525A1 (de) |
EP (1) | EP1622601B1 (de) |
AT (1) | ATE422356T1 (de) |
DE (1) | DE602004019405D1 (de) |
ES (1) | ES2325020T3 (de) |
GB (1) | GB0310919D0 (de) |
WO (1) | WO2004100941A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110257096A1 (en) * | 2004-08-25 | 2011-10-20 | Aegis Therapeutics, Inc. | Compositions for drug administration |
US9895444B2 (en) | 2004-08-25 | 2018-02-20 | Aegis Therapeutics, Llc | Compositions for drug administration |
US20140162965A1 (en) | 2004-08-25 | 2014-06-12 | Aegis Therapeutics, Inc. | Compositions for oral drug administration |
US20090047347A1 (en) * | 2005-07-29 | 2009-02-19 | Aegis Therapeutics, Inc. | Compositions for Drug Administration |
US8642564B2 (en) * | 2004-08-25 | 2014-02-04 | Aegis Therapeutics, Llc | Compositions for drug administration |
US20060046969A1 (en) * | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Antibacterial compositions for drug administration |
US20060046962A1 (en) | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
KR100815040B1 (ko) * | 2005-01-31 | 2008-03-18 | 주식회사종근당 | 비스포스포네이트계 약물의 경구흡수 개선을 위한약제학적 조성물 |
DE102005013958A1 (de) * | 2005-03-26 | 2006-09-28 | Clariant Produkte (Deutschland) Gmbh | Verwendung von Stabilisatoren in Phosphorhaltigen thermostabilisierten Flammschutzmittelagglomeraten |
US8226949B2 (en) | 2006-06-23 | 2012-07-24 | Aegis Therapeutics Llc | Stabilizing alkylglycoside compositions and methods thereof |
EP2213282A1 (de) * | 2009-01-30 | 2010-08-04 | Laboratorios Farmaceuticos Rovi, S.A. | Pharmazeutische Formen zur Freisetzung von Wirkstoffen |
US20090258865A1 (en) * | 2008-03-28 | 2009-10-15 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
US8440631B2 (en) | 2008-12-22 | 2013-05-14 | Aegis Therapeutics, Llc | Compositions for drug administration |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
CA2769633C (en) | 2009-07-31 | 2017-06-06 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
CN102469782A (zh) | 2010-06-18 | 2012-05-23 | 哈洛资源公司 | 包含壳聚糖的固态共混物的制剂及方法 |
US9340565B2 (en) | 2010-11-24 | 2016-05-17 | Thar Pharmaceuticals, Inc. | Crystalline forms |
PL3415139T3 (pl) | 2011-06-14 | 2022-07-11 | Neurelis, Inc. | Podawanie benzodiazepiny |
US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
JP6941224B2 (ja) | 2018-02-06 | 2021-09-29 | イージス セラピューティクス,エルエルシー | 疾患の処置のための鼻腔内エピネフリン製剤及び方法 |
JOP20180128A1 (ar) * | 2018-12-24 | 2020-06-24 | Univ Of Petra | صيغة دوائية صلبة قابلة للتشتت في الفم |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8904370D0 (en) | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
US5744166A (en) * | 1989-02-25 | 1998-04-28 | Danbiosyst Uk Limited | Drug delivery compositions |
JP3426230B2 (ja) * | 1991-05-20 | 2003-07-14 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | 複数層の制御放出処方剤 |
US5468503A (en) * | 1992-08-13 | 1995-11-21 | Teikoku Seiyaku Kabushiki Kaisha | Oral pharmaceutical preparation released at infragastrointestinal tract |
AU689250B2 (en) * | 1994-04-22 | 1998-03-26 | Astellas Pharma Inc. | Colon-specific drug release system |
US20010007673A1 (en) * | 1999-11-12 | 2001-07-12 | Merrill Seymour Goldenberg | Sustained-release delayed gels |
GB9713980D0 (en) | 1997-07-03 | 1997-09-10 | Danbiosyst Uk | New conjugates |
DE69917784T2 (de) * | 1998-07-30 | 2004-12-02 | Vital Living, Inc., Phoenix | Flüssige chitosan-enthaltende zusammensetzungen und verfahren zur herstellung und verwendung |
JP3761783B2 (ja) * | 1998-08-14 | 2006-03-29 | エフ.ホフマン−ラ ロシュ アーゲー | リパーゼ阻害剤とキトサンを含む製薬学的組成物 |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
JP2000290187A (ja) * | 1999-04-05 | 2000-10-17 | Toshio Sato | キトサン入りソフトカプセル及びその製造方法 |
SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
US6458383B2 (en) * | 1999-08-17 | 2002-10-01 | Lipocine, Inc. | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
-
2003
- 2003-05-13 GB GBGB0310919.6A patent/GB0310919D0/en not_active Ceased
-
2004
- 2004-05-13 AT AT04732650T patent/ATE422356T1/de not_active IP Right Cessation
- 2004-05-13 DE DE602004019405T patent/DE602004019405D1/de not_active Expired - Lifetime
- 2004-05-13 WO PCT/GB2004/002057 patent/WO2004100941A1/en active Application Filing
- 2004-05-13 EP EP04732650A patent/EP1622601B1/de not_active Expired - Lifetime
- 2004-05-13 ES ES04732650T patent/ES2325020T3/es not_active Expired - Lifetime
-
2005
- 2005-11-12 US US11/271,403 patent/US20060115525A1/en not_active Abandoned
-
2010
- 2010-04-23 US US12/766,487 patent/US8709996B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
GB0310919D0 (en) | 2003-06-18 |
EP1622601B1 (de) | 2009-02-11 |
ES2325020T3 (es) | 2009-08-24 |
US20060115525A1 (en) | 2006-06-01 |
EP1622601A1 (de) | 2006-02-08 |
US8709996B2 (en) | 2014-04-29 |
DE602004019405D1 (de) | 2009-03-26 |
WO2004100941A1 (en) | 2004-11-25 |
US20100203119A1 (en) | 2010-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE422356T1 (de) | Pharmazeutische zubereitungen | |
EA200400432A1 (ru) | Производные мочевины | |
CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
TR200100894T2 (tr) | Aril ikameli propanolamin türevleri, imalat yöntemleri, ilaç maddeleri, kullanımları. | |
EP1496076A4 (de) | Hydrophiles polymerderivat mit y-verzweigung und herstellungsverfahren dafür; obige verbindung enthaltender medizinischer verbundwerkstoff | |
BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
RU95101048A (ru) | Производные пролинамида, фармкомпозиция на их основе | |
CA2478621A1 (en) | Botulinum toxin pharmaceutical compositions | |
CY1112376T1 (el) | Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2 | |
BR0210139A (pt) | Composições farmacêuticas | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
CY1105028T1 (el) | Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες | |
NO20063277L (no) | Farmasoytisk sammensetning av vinflunin som er ment for parenteral administrering, fremstillingsmate og anvendelse derav | |
DE60313359D1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
DE69635996D1 (de) | Pharmazeutische zusammensetzungen mit hydroximsäurederivaten | |
ATE386725T1 (de) | Heterocyclylverbindungen | |
CY1107819T1 (el) | Φαρμακευτικη διαμορφωση της ολανζαπινης | |
EA200501105A1 (ru) | Фармацевтическая композиция | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
ATE549015T1 (de) | Pharmazeutische wirkstoffhaltige formulierung mit überzug | |
CY1105019T1 (el) | Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες | |
EA200501129A1 (ru) | Парентеральные композиции пептида для лечения системной красной волчанки | |
MEP31308A (en) | Lyophilized and liquid preparations comprising a polysaccharide derivative of camptothecin | |
WO2004039326A3 (en) | Propofol with cysteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |